PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
10462544-4	1999	We showed that the recombinant UMP-CMP kinase phosphorylated CMP, dCMP, and UMP with highest efficiency and dUMP, AMP, and dAMP with lower efficiency.	Deoxycytidine Monophosphate	66-70	cytidine/uridine monophosphate kinase 1	Homo sapiens	31-45
12044876-2	2002	We show that purified REV1 protein inserts dCMP opposite template G, A, T and C, and dGMP and dTMP opposite template G in the presence of magnesium, while in the presence of manganese the specificity for dCMP was found to be relaxed and the REV1 protein acquired the ability to insert dCMP, dGMP, dAMP and dTMP opposite templates G, A, T, and C. Kinetic analysis provided evidence for high affinity for dCTP with template G, suggesting that the REV1 protein is specialized for dCTP and template G.	Deoxycytidine Monophosphate	43-47	REV1 DNA directed polymerase	Homo sapiens	22-26
12044876-2	2002	We show that purified REV1 protein inserts dCMP opposite template G, A, T and C, and dGMP and dTMP opposite template G in the presence of magnesium, while in the presence of manganese the specificity for dCMP was found to be relaxed and the REV1 protein acquired the ability to insert dCMP, dGMP, dAMP and dTMP opposite templates G, A, T, and C. Kinetic analysis provided evidence for high affinity for dCTP with template G, suggesting that the REV1 protein is specialized for dCTP and template G.	Deoxycytidine Monophosphate	204-208	REV1 DNA directed polymerase	Homo sapiens	22-26
12044876-2	2002	We show that purified REV1 protein inserts dCMP opposite template G, A, T and C, and dGMP and dTMP opposite template G in the presence of magnesium, while in the presence of manganese the specificity for dCMP was found to be relaxed and the REV1 protein acquired the ability to insert dCMP, dGMP, dAMP and dTMP opposite templates G, A, T, and C. Kinetic analysis provided evidence for high affinity for dCTP with template G, suggesting that the REV1 protein is specialized for dCTP and template G.	Deoxycytidine Monophosphate	204-208	REV1 DNA directed polymerase	Homo sapiens	22-26
11917024-0	2002	Response of human REV1 to different DNA damage: preferential dCMP insertion opposite the lesion.	Deoxycytidine Monophosphate	61-65	REV1 DNA directed polymerase	Homo sapiens	18-22
11917024-3	2002	Lacking a 3"-->5" proofreading exonuclease activity, purified human REV1 exhibited a DNA polymerase activity on a repeating template G sequence, but catalyzed nucleotide insertion with 6-fold lower efficiency opposite a template A and 19-27-fold lower efficiency opposite a template T or C. Furthermore, dCMP insertion was greatly preferred regardless of the specific template base.	Deoxycytidine Monophosphate	307-311	REV1 DNA directed polymerase	Homo sapiens	71-75
11917024-4	2002	Human REV1 inserted a dCMP efficiently opposite a template 8-oxoguanine, (+)-trans-anti-benzo[a]pyrene-N2-dG, (-)-trans-anti-benzo[a]pyrene-N2-dG and 1,N6-ethenoadenine adducts, very inefficiently opposite an acetylaminofluorene-adducted guanine, but was unresponsive to a template TT dimer or TT (6-4) photoproduct.	Deoxycytidine Monophosphate	22-26	REV1 DNA directed polymerase	Homo sapiens	6-10
11917024-6	2002	By combining the dCMP insertion activity of human REV1 with the extension synthesis activity of human polymerase kappa, bypass of the trans-anti-benzo[a]pyrene-N2-dG adducts and the 1,N6-ethenoadenine lesion was achieved by the two-polymerase two-step mechanism.	Deoxycytidine Monophosphate	17-21	REV1 DNA directed polymerase	Homo sapiens	50-54
11917024-7	2002	These results suggest that human REV1 is a specialized DNA polymerase that may contribute to dCMP insertion opposite many types of DNA damage during lesion bypass.	Deoxycytidine Monophosphate	93-97	REV1 DNA directed polymerase	Homo sapiens	33-37
11711549-1	2002	The Rev1 protein, a member of a large family of translesion DNA polymerases, catalyzes a dCMP transfer reaction.	Deoxycytidine Monophosphate	89-93	REV1, DNA directed polymerase	Mus musculus	4-8
11711549-2	2002	Recombinant mouse Rev1 protein was found to insert a dCMP residue opposite guanine, adenine, thymine, cytosine, uracil, and an apurinic/apyrimidinic site and to have weak ability for transfer to a mismatched terminus.	Deoxycytidine Monophosphate	53-57	REV1, DNA directed polymerase	Mus musculus	18-22
11711549-5	2002	Furthermore, it could be established that the mouse Rev1 protein inserts dGMP and dTMP residues opposite template guanine at a V(max) similar to that for dCMP.	Deoxycytidine Monophosphate	154-158	REV1, DNA directed polymerase	Mus musculus	52-56
11393704-6	2001	Finally, the optimised system was successfully tested on the nucleotide mixture solution to determine the methylation state of 2"-deoxycytidine-5"-monophosphate in DNA in the search for FMR1 gene changes.	Deoxycytidine Monophosphate	127-160	fragile X messenger ribonucleoprotein 1	Homo sapiens	186-190
11278384-8	2001	Therefore, the molecular mechanism of the dCMP transfer reaction of the REV1S protein and maybe also the REV1 protein might be the same as that of the dNTP transfer reaction of the translesion DNA polymerases.	Deoxycytidine Monophosphate	42-46	REV1 DNA directed polymerase	Homo sapiens	72-76
10536157-7	1999	We show that the human REV1 protein is a dCMP transferase that specifically inserts a dCMP residue opposite a DNA template G. In addition, the human REV1 transferase is able to efficiently and specifically insert a dCMP opposite a DNA template apurinic/apyrimidinic (AP) site or a uracil residue.	Deoxycytidine Monophosphate	41-45	REV1 DNA directed polymerase	Homo sapiens	23-27
10536157-7	1999	We show that the human REV1 protein is a dCMP transferase that specifically inserts a dCMP residue opposite a DNA template G. In addition, the human REV1 transferase is able to efficiently and specifically insert a dCMP opposite a DNA template apurinic/apyrimidinic (AP) site or a uracil residue.	Deoxycytidine Monophosphate	41-45	REV1 DNA directed polymerase	Homo sapiens	149-153
10536157-7	1999	We show that the human REV1 protein is a dCMP transferase that specifically inserts a dCMP residue opposite a DNA template G. In addition, the human REV1 transferase is able to efficiently and specifically insert a dCMP opposite a DNA template apurinic/apyrimidinic (AP) site or a uracil residue.	Deoxycytidine Monophosphate	86-90	REV1 DNA directed polymerase	Homo sapiens	23-27
10536157-7	1999	We show that the human REV1 protein is a dCMP transferase that specifically inserts a dCMP residue opposite a DNA template G. In addition, the human REV1 transferase is able to efficiently and specifically insert a dCMP opposite a DNA template apurinic/apyrimidinic (AP) site or a uracil residue.	Deoxycytidine Monophosphate	86-90	REV1 DNA directed polymerase	Homo sapiens	149-153
11133996-6	2001	The recombinant cN-I showed high affinity toward dCMP and lower affinity toward AMP and IMP.	Deoxycytidine Monophosphate	49-53	5'-nucleotidase, cytosolic IA	Homo sapiens	16-20
10931348-2	2000	We showed previously that Rev1p possesses a deoxycytidyl transferase activity, which incorporates dCMP opposite abasic sites in the DNA template, and that dCMP insertion is the major event during bypass of an abasic site in vivo.	Deoxycytidine Monophosphate	98-102	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	26-31
10931348-2	2000	We showed previously that Rev1p possesses a deoxycytidyl transferase activity, which incorporates dCMP opposite abasic sites in the DNA template, and that dCMP insertion is the major event during bypass of an abasic site in vivo.	Deoxycytidine Monophosphate	155-159	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	26-31
10931348-3	2000	However, we now find that Rev1p function is needed for the bypass of a T-T (6-4) UV photoproduct, a process in which dCMP incorporation occurs only very rarely, indicating that Rev1p possesses a second function.	Deoxycytidine Monophosphate	117-121	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	26-31
9753470-4	1998	Using pol alpha and delta, 2-OHE1-N2-dG promoted incorporation of dCMP (6.3 and 3.1%, respectively), the correct base, opposite the lesion: when pol delta was used, misincorporation of dTMP (0.52%) was detected.	Deoxycytidine Monophosphate	66-70	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	6-15
9776180-1	1998	Previously, we determined that elimination of deoxycytidylate (dCMP) deaminase (DCD1) in the yeast Saccharomyces cerevisiae increases the intracellular dCTP:dTTP ratio and reduces the induction of G x C --> A x T transitions in the SUP4-o gene by ethyl methanesulfonate (EMS) and N-methyl-N"-nitro-N-nitrosoguanidine (MNNG).	Deoxycytidine Monophosphate	63-67	deoxycytidine monophosphate deaminase	Saccharomyces cerevisiae S288C	80-84
9596658-10	1998	Most probably, CDD exerts growth inhibition by depleting the cytidine and deoxycytidine pool required for DNA synthesis, as addition of deoxycytidine monophosphate, which is not a substrate for CDD, neutralizes the inhibiting effect.	Deoxycytidine Monophosphate	136-163	cytidine deaminase	Homo sapiens	15-18
9602145-7	1998	The URA6 homologue protein produced in Escherichia coli using the glutathione S-transferase gene fusion system was found to catalyze the phosphoryl transfer from ATP to UMP and CMP efficiently and also to AMP and dCMP with lower efficiencies.	Deoxycytidine Monophosphate	213-217	bifunctional uridylate/adenylate kinase	Saccharomyces cerevisiae S288C	4-8
9776180-1	1998	Previously, we determined that elimination of deoxycytidylate (dCMP) deaminase (DCD1) in the yeast Saccharomyces cerevisiae increases the intracellular dCTP:dTTP ratio and reduces the induction of G x C --> A x T transitions in the SUP4-o gene by ethyl methanesulfonate (EMS) and N-methyl-N"-nitro-N-nitrosoguanidine (MNNG).	Deoxycytidine Monophosphate	63-67	cut up	Drosophila melanogaster	152-156
9776180-1	1998	Previously, we determined that elimination of deoxycytidylate (dCMP) deaminase (DCD1) in the yeast Saccharomyces cerevisiae increases the intracellular dCTP:dTTP ratio and reduces the induction of G x C --> A x T transitions in the SUP4-o gene by ethyl methanesulfonate (EMS) and N-methyl-N"-nitro-N-nitrosoguanidine (MNNG).	Deoxycytidine Monophosphate	63-67	SUP4	Saccharomyces cerevisiae S288C	235-239
8751446-4	1996	We show here that Rev1 protein has a deoxycytidyl transferase activity which transfers a dCMP residue from dCTP to the 3" end of a DNA primer in a template-dependent reaction.	Deoxycytidine Monophosphate	89-93	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	18-22
9335562-4	1997	Pol alpha catalyzed incorporation of dCMP and dAMP opposite all four stereoisomers of dG-N2-tamoxifen, accompanied by lesser amounts of dGMP.	Deoxycytidine Monophosphate	37-41	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	0-9
9335562-6	1997	Using pol beta, preferential incorporation of dCMP, along with small amounts of incorporation of dAMP and dGMP, was detected.	Deoxycytidine Monophosphate	46-50	DNA polymerase beta	Homo sapiens	6-14
8942665-3	1996	Pol alpha catalyzed incorporation of dTMP and dAMP opposite epsilon dC, accompanied by lesser amounts of dCMP and dGMP and some two-base deletions.	Deoxycytidine Monophosphate	105-109	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	0-9
8942665-4	1996	Pol beta promoted incorporation of dCMP and dAMP, along with small amounts of one-base and two-base deletions.	Deoxycytidine Monophosphate	35-39	DNA polymerase beta	Homo sapiens	0-8
7748494-2	1995	Restriction enzymes, including Sma I, Pst I, Bam HI, Hind III, and Hinc II, were completely inactive when their recognition sites were fully substituted with Hg-dCMP, while Hg-dUMP containing DNA was hydroxlyzed to some extent.	Deoxycytidine Monophosphate	161-165	sulfotransferase family 1A member 1	Homo sapiens	38-41
8611496-1	1996	Thymidylate synthase (TS) methylates only dUMP, not dCMP.	Deoxycytidine Monophosphate	52-56	thymidylate synthetase	Homo sapiens	0-20
8977026-5	1996	Rev1 protein is a terminal nucleotidyl transferase that inserts dCMP opposite template G, A and abasic sites.	Deoxycytidine Monophosphate	64-68	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	0-4
8369294-0	1993	Exclusion of 2"-deoxycytidine 5"-monophosphate by asparagine 229 of thymidylate synthase.	Deoxycytidine Monophosphate	13-46	thymidylate synthetase	Homo sapiens	68-88
8294475-1	1994	Adenovirus preterminal protein (pTP) exists as a heterodimer with the viral DNA polymerase (AdPol) and becomes covalently linked to a dCMP residue during initiation of DNA replication.	Deoxycytidine Monophosphate	134-138	protein tyrosine phosphatase receptor type U	Homo sapiens	32-35
8450671-6	1993	Substrate specificity was the same for both enzymes with the following relative Vmax values: CMP > UMP > dUMP > dCMP > dAMP > IMP > GMP > dIMP > dGMP.	Deoxycytidine Monophosphate	121-125	5'-nucleotidase, cytosolic II	Homo sapiens	150-153
8441675-7	1993	Since Oct-1 does not stabilize binding of pTP-pol to the origin this suggests that Oct-1 increases the rate of pTP-dCMP formation.	Deoxycytidine Monophosphate	115-119	POU class 2 homeobox 1	Homo sapiens	83-88
2621800-7	1989	Under the diagnosis of acute myelomonocytic leukemia with eosinophilia (M4Eo) associated with inv (16) (p13 q22), one course of DCMP induction therapy was performed.	Deoxycytidine Monophosphate	128-132	inversin	Homo sapiens	94-97
1814437-4	1991	The level of DNA polymerase alpha activity was found to gradually decrease by 60% (2.3 to 0.8 nmol of [3H]dCMP incorporated/mg protein/h) between 9- and 19-day-old ECB.	Deoxycytidine Monophosphate	106-110	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	13-33
1831456-7	1991	The 2-fold stimulation of pTP.dCMP formation by the DBP was lost by prior heating of the ts DBPs.	Deoxycytidine Monophosphate	30-34	zinc finger protein 763	Homo sapiens	52-55
1429652-5	1992	In the absence of the second substrate, dNTP, DNA pol alpha binds with approximately equal affinities to DNA templates that contain oligonucleotide primers with araCMP or dCMP positioned at the 3" terminus.	Deoxycytidine Monophosphate	171-175	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	50-59
28835847-10	2017	There was a significant interaction between time and being at goal pre-DCMP for HbA1c, SBP and LDL.	Deoxycytidine Monophosphate	71-75	selenium binding protein 1	Homo sapiens	87-90
35089032-9	2022	DNA polymerase beta mostly incorporated dAMP and dCMP, preferring dCMP opposite to the natural AP site and dAMP opposite to the MX-AP site, while DNA polymerase lambda was selective for dGMP, apparently via the primer misalignment mechanism.	Deoxycytidine Monophosphate	49-53	DNA polymerase beta	Homo sapiens	0-19
35089032-9	2022	DNA polymerase beta mostly incorporated dAMP and dCMP, preferring dCMP opposite to the natural AP site and dAMP opposite to the MX-AP site, while DNA polymerase lambda was selective for dGMP, apparently via the primer misalignment mechanism.	Deoxycytidine Monophosphate	66-70	DNA polymerase beta	Homo sapiens	0-19
2822457-5	1987	dNase activity occurred with both purine and pyrimidine substrates and was maximal with deoxy analogs (dIMP much greater than dUMP greater than dGMP greater than dTMP = dAMP much greater than dCMP) at a pH optimum of 6.2, but slight cross-reactivity occurred with some nondeoxy substrates (IMP greater than GMP greater than UMP = XMP greater than CMP).	Deoxycytidine Monophosphate	192-196	Deoxyribonuclease II	Drosophila melanogaster	0-5
2763196-2	1989	The mean level of C3a in DCMP patients (572 +/- 55 ng/ml) was significantly higher than in HCMP patients (344 +/- 30 ng/ml) and in donors (294 +/- 43 ng/ml) (p less than 0.001).	Deoxycytidine Monophosphate	25-29	complement C3	Homo sapiens	18-21
2763196-4	1989	It has been established that in the group of DCMP patients with thromboembolic complications, the concentrations of C3a (736 +/- 95 ng/ml) were significantly higher than in those without such complications (334 +/- 14 ng/ml) (p less than 0.001).	Deoxycytidine Monophosphate	45-49	complement C3	Homo sapiens	116-119
6166921-3	1981	Instead, the cDNA is dCMP-tailed at its 3"-end with terminal deoxynucleotidyl transferase (TdT).	Deoxycytidine Monophosphate	21-25	DNA nucleotidylexotransferase	Gallus gallus	52-89
3501296-6	1987	The study of HLA-antigens distribution in patients with DCMP revealed greater prevalence of DR1 and DR4 antigens.	Deoxycytidine Monophosphate	56-60	down-regulator of transcription 1	Homo sapiens	92-95
3501296-6	1987	The study of HLA-antigens distribution in patients with DCMP revealed greater prevalence of DR1 and DR4 antigens.	Deoxycytidine Monophosphate	56-60	major histocompatibility complex, class II, DR beta 4	Homo sapiens	100-103
6572922-5	1983	The reactions studied depend on the presence of the DNA template and include the initiation reaction (the covalent attachment of dCMP to the pTP) and the selective replication of Ad DNA restriction endonuclease fragments containing the origin sequences.	Deoxycytidine Monophosphate	129-133	protein tyrosine phosphatase receptor type U	Homo sapiens	141-144
6947251-2	1981	pTP was assayed by its ability to form a covalent complex with dCMP.	Deoxycytidine Monophosphate	63-67	protein tyrosine phosphatase receptor type U	Homo sapiens	0-3
6581381-6	1983	Deoxycytidylate deaminase exhibited the greatest affinity for the substrate dCMP, with lesser affinity for ara-CMP, and least affinity for CMP.	Deoxycytidine Monophosphate	76-80	dCMP deaminase	Homo sapiens	0-25
6297776-3	1982	The defect lies in the first step in the initiation of viral DNA synthesis, the formation of a covalent linkage between the terminal protein precursor (pTP) and dCMP.	Deoxycytidine Monophosphate	161-165	protein tyrosine phosphatase receptor type U	Homo sapiens	152-155
6216480-4	1982	In the presence of Ad DNA-prot, the Ad-protein fraction (containing the pTP and the Ad-associated DNA polymerase), ATP, Mg2+, and dCTP, nuclear factor I stimulates formation of the pTP-dCMP complex.	Deoxycytidine Monophosphate	185-189	protein tyrosine phosphatase receptor type U	Homo sapiens	72-75
6216480-4	1982	In the presence of Ad DNA-prot, the Ad-protein fraction (containing the pTP and the Ad-associated DNA polymerase), ATP, Mg2+, and dCTP, nuclear factor I stimulates formation of the pTP-dCMP complex.	Deoxycytidine Monophosphate	185-189	protein tyrosine phosphatase receptor type U	Homo sapiens	181-184
6216480-8	1982	In the presence of Ad DBP, these sites are blocked thus creating a requirement for nuclear factor I in pTP-dCMP complex formation.	Deoxycytidine Monophosphate	107-111	protein tyrosine phosphatase receptor type U	Homo sapiens	103-106
6957861-6	1982	The covalent addition of dCMP, the first nucleotide in the DNA chain, to the pTP, which serves as the primer for replication, required the DNA polymerase subunit as well as the pTP.	Deoxycytidine Monophosphate	25-29	protein tyrosine phosphatase receptor type U	Homo sapiens	77-80
6957861-6	1982	The covalent addition of dCMP, the first nucleotide in the DNA chain, to the pTP, which serves as the primer for replication, required the DNA polymerase subunit as well as the pTP.	Deoxycytidine Monophosphate	25-29	protein tyrosine phosphatase receptor type U	Homo sapiens	177-180
6166921-3	1981	Instead, the cDNA is dCMP-tailed at its 3"-end with terminal deoxynucleotidyl transferase (TdT).	Deoxycytidine Monophosphate	21-25	DNA nucleotidylexotransferase	Gallus gallus	91-94
28459633-4	2017	In addition, we observed that the binding of DOX to CMPK1 activated the phosphorylation of CMP, dCMP, and UMP.	Deoxycytidine Monophosphate	96-100	cytidine/uridine monophosphate kinase 1	Homo sapiens	52-57
6456362-4	1981	Mutations in the alc/unf gene (which allow dCMP-containing T4 late genes to be expressed) further increased complementation efficiency.	Deoxycytidine Monophosphate	43-47	Alc inhibitor of host transcription	Escherichia phage T4	17-20
6456362-4	1981	Mutations in the alc/unf gene (which allow dCMP-containing T4 late genes to be expressed) further increased complementation efficiency.	Deoxycytidine Monophosphate	43-47	Alc inhibitor of host transcription	Escherichia phage T4	21-24
6456362-5	1981	Most of the alc/unf mutant phage strains used for these experiments were constructed to incorporate a gene 56 mutation, which blocks dCTP breakdown and allows replication to generate dCMP-containing T4 DNA.	Deoxycytidine Monophosphate	183-187	Alc inhibitor of host transcription	Escherichia phage T4	12-15
32633759-5	2020	A dCMP residue was faithfully inserted across the ICL-G by Pol eta, Pol zeta, and Rev1-Pol zeta.	Deoxycytidine Monophosphate	2-6	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	82-86
31391279-6	2019	We show that overexpression of human dCMP deaminase (DCTD), an enzyme that provides directly dUMP through dCMP deamination, does not reverse the lethal phenotype of dUTPase knockout cells, which further supports the notion that in T. brucei, CDA is uniquely involved in providing dUMP, while the main role of dUTPase would be the withdrawal of the excess of dUTP to avoid its incorporation into DNA.	Deoxycytidine Monophosphate	37-41	dCMP deaminase	Homo sapiens	53-57
28878024-4	2017	Here, we report the 2.8-A resolution crystal structure of AtSWEET13 in the inward-facing conformation with a substrate analog, 2"-deoxycytidine 5"-monophosphate, bound in the central cavity.	Deoxycytidine Monophosphate	127-160	Nodulin MtN3 family protein	Arabidopsis thaliana	58-67
14468886-2	1962	The effect of halogenated and N-methyl derivatives of deoxycytidylic acid on deoxycytidylate deaminase and thymidylate synthetase.	Deoxycytidine Monophosphate	54-73	dCMP deaminase	Homo sapiens	77-102
14468886-2	1962	The effect of halogenated and N-methyl derivatives of deoxycytidylic acid on deoxycytidylate deaminase and thymidylate synthetase.	Deoxycytidine Monophosphate	54-73	thymidylate synthetase	Homo sapiens	107-129
32853828-5	2020	Moreover, the nicked repair intermediates that mimic pol beta mismatch insertion products, i.e., with 3"-preinserted dGMP or dTMP opposite templating 5hmC, 5fC or 5caC, can be efficiently ligated, whereas preinserted 3"-dAMP or dCMP mismatches result in failed ligation reactions.	Deoxycytidine Monophosphate	228-232	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	53-61
31377845-7	2020	Our data indicate that DCTPP1 is crucially involved in the provision of dCMP for thymidylate biosynthesis, introducing a new player in the regulation of pyrimidine dNTP levels and the maintenance of genomic integrity.	Deoxycytidine Monophosphate	72-76	dCTP pyrophosphatase 1	Homo sapiens	23-29
30867918-1	2019	To protect viral DNA against the host bacterial restriction system, bacterio-phages utilize a special modification system - hydroxymethylation - in which dCMP hydroxymethylase (dCH) converts dCMP to 5-hydroxymethyl-dCMP (5hm-dCMP) using N5,N10-methylenetetrahydrofolate as a cofactor.	Deoxycytidine Monophosphate	154-158	dch	Drosophila melanogaster	177-180
28682600-3	2017	Previously, we have shown hPolbeta-catalyzed 8-oxoG bypass to exhibit low fidelity and identified a unique stacking interaction between the newly incorporated nucleotide (dCMP or dAMP) and the templating 8-oxoG.	Deoxycytidine Monophosphate	171-175	DNA polymerase beta	Homo sapiens	26-34
28757211-5	2017	By solving crystal structures of maltose binding protein (MBP)-fused AID alone and in complex with deoxycytidine monophosphate, we surprisingly identify a bifurcated substrate-binding surface that explains structured substrate recognition by capturing two adjacent single-stranded overhangs simultaneously.	Deoxycytidine Monophosphate	99-126	myelin basic protein	Homo sapiens	33-56
28757211-5	2017	By solving crystal structures of maltose binding protein (MBP)-fused AID alone and in complex with deoxycytidine monophosphate, we surprisingly identify a bifurcated substrate-binding surface that explains structured substrate recognition by capturing two adjacent single-stranded overhangs simultaneously.	Deoxycytidine Monophosphate	99-126	myelin basic protein	Homo sapiens	58-61
28757211-5	2017	By solving crystal structures of maltose binding protein (MBP)-fused AID alone and in complex with deoxycytidine monophosphate, we surprisingly identify a bifurcated substrate-binding surface that explains structured substrate recognition by capturing two adjacent single-stranded overhangs simultaneously.	Deoxycytidine Monophosphate	99-126	activation induced cytidine deaminase	Homo sapiens	69-72
28318037-3	2017	Molecular bypass therapy with the TK2 products, deoxycytidine monophosphate (dCMP) and deoxythymidine monophosphate (dTMP), prolongs the life span of Tk2-deficient (Tk2-/- ) mice by 2- to 3-fold.	Deoxycytidine Monophosphate	48-75	thymidine kinase 2, mitochondrial	Mus musculus	34-37
28318037-3	2017	Molecular bypass therapy with the TK2 products, deoxycytidine monophosphate (dCMP) and deoxythymidine monophosphate (dTMP), prolongs the life span of Tk2-deficient (Tk2-/- ) mice by 2- to 3-fold.	Deoxycytidine Monophosphate	48-75	thymidine kinase 2, mitochondrial	Mus musculus	150-153
28318037-3	2017	Molecular bypass therapy with the TK2 products, deoxycytidine monophosphate (dCMP) and deoxythymidine monophosphate (dTMP), prolongs the life span of Tk2-deficient (Tk2-/- ) mice by 2- to 3-fold.	Deoxycytidine Monophosphate	77-81	thymidine kinase 2, mitochondrial	Mus musculus	34-37
28318037-3	2017	Molecular bypass therapy with the TK2 products, deoxycytidine monophosphate (dCMP) and deoxythymidine monophosphate (dTMP), prolongs the life span of Tk2-deficient (Tk2-/- ) mice by 2- to 3-fold.	Deoxycytidine Monophosphate	77-81	thymidine kinase 2, mitochondrial	Mus musculus	150-153
28318037-7	2017	In contrast, dCMP+dTMP+THU therapy decreased life span of Tk2-/- animals compared to dCMP+dTMP.	Deoxycytidine Monophosphate	13-17	thymidine kinase 2, mitochondrial	Mus musculus	58-61
25226389-13	2014	In human cells, targeted one-base deletion was undetectable, and dTMP>dCMP were the next preferred nucleotides inserted opposite Z. siRNA knockdown of Rev1 or pol zeta established that both these polymerases are vital for AP-site bypass, as demonstrated by 36-67% reduction in bypass efficiency.	Deoxycytidine Monophosphate	73-77	REV1 DNA directed polymerase	Homo sapiens	154-158
26748441-4	2016	Here we report high to medium resolution structures of native porcine RNase 4 (PL3), a "substrate-specificity" determining mutant D80A and their respective complexes with deoxyuridine 5"-monophosphate (dUMP) and deoxycytidine 5"-monophosphate (dCMP).	Deoxycytidine Monophosphate	212-242	ribonuclease A family member 4	Homo sapiens	70-77
26748441-4	2016	Here we report high to medium resolution structures of native porcine RNase 4 (PL3), a "substrate-specificity" determining mutant D80A and their respective complexes with deoxyuridine 5"-monophosphate (dUMP) and deoxycytidine 5"-monophosphate (dCMP).	Deoxycytidine Monophosphate	244-248	ribonuclease A family member 4	Homo sapiens	70-77
26748441-5	2016	These structures provide insight into the structural basis of the uridine versus cytosine substrate specificity in RNase 4: in the D80A mutant (D80A dCMP), the side chain of Arg101 is positioned further away from the substrate-binding pocket due to the loss of the Asp80 side chain, reducing the repulsion force on the less favoured dCMP from Arg101 and allowing the ligand to occupy the binding pocket.	Deoxycytidine Monophosphate	149-153	ribonuclease A family member 4	Homo sapiens	115-122
26748441-5	2016	These structures provide insight into the structural basis of the uridine versus cytosine substrate specificity in RNase 4: in the D80A mutant (D80A dCMP), the side chain of Arg101 is positioned further away from the substrate-binding pocket due to the loss of the Asp80 side chain, reducing the repulsion force on the less favoured dCMP from Arg101 and allowing the ligand to occupy the binding pocket.	Deoxycytidine Monophosphate	333-337	ribonuclease A family member 4	Homo sapiens	115-122
27683219-1	2016	Rev1 is a member of the Y-family of DNA polymerases and is known for its deoxycytidyl transferase activity that incorporates dCMP into DNA and its ability to function as a scaffold factor for other Y-family polymerases in translesion bypass events.	Deoxycytidine Monophosphate	125-129	REV1, DNA directed polymerase	Mus musculus	0-4
25199874-2	2014	METHODS: Non-hydrolyzable derivatives of AMPS and dCMPS, each containing the residue able to form a covalent bond in nucleic acid-protein complexes via photocrosslinking (at 308nm), were applied at the complexing experiments with recombinant and cellular Hint1.	Deoxycytidine Monophosphate	50-55	histidine triad nucleotide binding protein 1	Homo sapiens	255-260
25294835-4	2014	Steady-state kinetic analysis reveals that WRN improves hpol kappa-catalyzed dCMP insertion opposite 8-oxo-dG ~10-fold and extension from dC:8-oxo-dG by 2.4-fold.	Deoxycytidine Monophosphate	77-81	WRN RecQ like helicase	Homo sapiens	43-46
25255211-7	2014	PrimPol inserts dCMP opposite 8-oxo-dG with 2- (Mn2+) to 6-fold (Mg2+) greater efficiency than dAMP misinsertion.	Deoxycytidine Monophosphate	16-20	primase and DNA directed polymerase	Homo sapiens	0-7
25255211-8	2014	PrimPol-catalyzed dCMP insertion opposite 8-oxo-dG proceeds at ~25% efficiency relative to unmodified template dG, and PrimPol readily extends from dC:8-oxo-dG base pairs (bps) with ~2-fold greater efficiency than dA:8-oxo-dG bps.	Deoxycytidine Monophosphate	18-22	primase and DNA directed polymerase	Homo sapiens	0-7
24366879-5	2014	The pre-steady-state rate constant of deoxycytidine monophosphate (dCMP) insertion opposite the first tetrad-guanine by hRev1 is ~56% as fast as that observed for non-G4 DNA substrates.	Deoxycytidine Monophosphate	38-65	REV1 DNA directed polymerase	Homo sapiens	120-125
24968719-3	2014	Assessment of 13-day-old Tk2(-/-) mice treated with dCMP+dTMP 200 mg/kg/day each (Tk2(-/-200dCMP/) (dTMP)) demonstrated that in mutant animals, the compounds raise dTTP concentrations, increase levels of mtDNA, ameliorate defects of mitochondrial respiratory chain enzymes, and significantly prolong their lifespan (34 days with treatment versus 13 days untreated).	Deoxycytidine Monophosphate	52-56	thymidine kinase 2, mitochondrial	Mus musculus	25-28
24968719-3	2014	Assessment of 13-day-old Tk2(-/-) mice treated with dCMP+dTMP 200 mg/kg/day each (Tk2(-/-200dCMP/) (dTMP)) demonstrated that in mutant animals, the compounds raise dTTP concentrations, increase levels of mtDNA, ameliorate defects of mitochondrial respiratory chain enzymes, and significantly prolong their lifespan (34 days with treatment versus 13 days untreated).	Deoxycytidine Monophosphate	52-56	thymidine kinase 2, mitochondrial	Mus musculus	82-85
24366879-5	2014	The pre-steady-state rate constant of deoxycytidine monophosphate (dCMP) insertion opposite the first tetrad-guanine by hRev1 is ~56% as fast as that observed for non-G4 DNA substrates.	Deoxycytidine Monophosphate	67-71	REV1 DNA directed polymerase	Homo sapiens	120-125
22024240-5	2011	Results with this assay suggest that dCMP is the most frequent dNMP inserted opposite uracil-derived AP sites and demonstrate that dCMP insertion absolutely requires the catalytic activity of Rev1.	Deoxycytidine Monophosphate	37-41	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	192-196
23076070-10	2013	Pol alpha and eta, on the other hand, exclusively incorporated dCMP opposite the lesion.	Deoxycytidine Monophosphate	63-67	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	0-9
23076070-10	2013	Pol alpha and eta, on the other hand, exclusively incorporated dCMP opposite the lesion.	Deoxycytidine Monophosphate	63-67	endothelin receptor type A	Homo sapiens	14-17
22811935-5	2012	In the present study the MT-CYB gene was analysed in 30 patients with hCMP, 40 patients with dCMP, and 50 controls for alterations.	Deoxycytidine Monophosphate	93-97	mitochondrially encoded cytochrome b	Homo sapiens	25-31
22024240-5	2011	Results with this assay suggest that dCMP is the most frequent dNMP inserted opposite uracil-derived AP sites and demonstrate that dCMP insertion absolutely requires the catalytic activity of Rev1.	Deoxycytidine Monophosphate	131-135	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	192-196
22024240-6	2011	In the complementary nonsense-reversion assay, dCMP insertion likewise depended on the dCMP transferase activity of Rev1.	Deoxycytidine Monophosphate	47-51	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	116-120
22024240-8	2011	These results demonstrate that the catalytic activity of Rev1 is biologically relevant and is required specifically for dCMP insertion during the bypass of endogenous AP sites.	Deoxycytidine Monophosphate	120-124	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	57-61
21078407-4	2011	Remarkably, the substitution of alanine for phenylalanine 171 (F171), an amino acid conserved between Pol kappa and its bacterial counterpart Escherichia coli DinB, enhanced the efficiencies of dCMP incorporation opposite (-)- and (+)-trans-anti-BPDE-N(2)-dG 18-fold.	Deoxycytidine Monophosphate	194-198	DNA polymerase lambda	Homo sapiens	102-111
21567966-7	2011	Among the series of pyrimidine analogues, one derivative was shown to be phosphorylated by human UMP-CMP kinase, with rates similar to those of dUMP and even better than dCMP.	Deoxycytidine Monophosphate	170-174	cytidine/uridine monophosphate kinase 1	Homo sapiens	97-111
21080915-6	2011	AK7, full-length AK8, AK8p1 and AK8p2 phosphorylated AMP, CMP, dAMP and dCMP with ATP as the phosphate donor, and also AMP, CMP and dCMP with GTP as the phosphate donor.	Deoxycytidine Monophosphate	72-76	adenylate kinase 7	Homo sapiens	0-3
21080915-6	2011	AK7, full-length AK8, AK8p1 and AK8p2 phosphorylated AMP, CMP, dAMP and dCMP with ATP as the phosphate donor, and also AMP, CMP and dCMP with GTP as the phosphate donor.	Deoxycytidine Monophosphate	72-76	adenylate kinase 8	Homo sapiens	17-20
21080915-6	2011	AK7, full-length AK8, AK8p1 and AK8p2 phosphorylated AMP, CMP, dAMP and dCMP with ATP as the phosphate donor, and also AMP, CMP and dCMP with GTP as the phosphate donor.	Deoxycytidine Monophosphate	72-76	adenylate kinase 8	Homo sapiens	22-26
21080915-6	2011	AK7, full-length AK8, AK8p1 and AK8p2 phosphorylated AMP, CMP, dAMP and dCMP with ATP as the phosphate donor, and also AMP, CMP and dCMP with GTP as the phosphate donor.	Deoxycytidine Monophosphate	132-136	adenylate kinase 7	Homo sapiens	0-3
21080915-6	2011	AK7, full-length AK8, AK8p1 and AK8p2 phosphorylated AMP, CMP, dAMP and dCMP with ATP as the phosphate donor, and also AMP, CMP and dCMP with GTP as the phosphate donor.	Deoxycytidine Monophosphate	132-136	adenylate kinase 8	Homo sapiens	17-20
21080915-6	2011	AK7, full-length AK8, AK8p1 and AK8p2 phosphorylated AMP, CMP, dAMP and dCMP with ATP as the phosphate donor, and also AMP, CMP and dCMP with GTP as the phosphate donor.	Deoxycytidine Monophosphate	132-136	adenylate kinase 8	Homo sapiens	22-26
21491329-1	2011	The mitochondrial enzyme thymidine kinase 2 (TK2) phosphorylates deoxythymidine (dT) and deoxycytidine (dC) to form dTMP and dCMP, which in cells rapidly become the negative-feedback end-products dTTP and dCTP.	Deoxycytidine Monophosphate	125-129	thymidine kinase 2	Homo sapiens	25-43
21491329-1	2011	The mitochondrial enzyme thymidine kinase 2 (TK2) phosphorylates deoxythymidine (dT) and deoxycytidine (dC) to form dTMP and dCMP, which in cells rapidly become the negative-feedback end-products dTTP and dCTP.	Deoxycytidine Monophosphate	125-129	thymidine kinase 2	Homo sapiens	45-48
19766732-4	2010	The enzyme catalyzed the phosphorylation of AMP, dAMP, CMP and dCMP with ATP or GTP as phosphate donors and AK4 also phosphorylated AMP with UTP as phosphate donor.	Deoxycytidine Monophosphate	63-67	adenylate kinase 4	Homo sapiens	108-111
20940308-7	2010	Moreover, we found that not only AMPS but also other ribonucleoside and 2"-deoxyribonucleoside phosphorothioates are desulfurated by Hint-1 at the following relative rates: GMPS > AMPS > dGMPS >= CMPS > UMPS > dAMPS >> dCMPS > TMPS, and during the reaction, hydrogen sulfide, which is thought to be the third gaseous mediator, was released.	Deoxycytidine Monophosphate	240-245	histidine triad nucleotide binding protein 1	Homo sapiens	133-139
20726503-8	2010	dCMP and dTMP were most frequently inserted by hPol iota, and only dCMP was inserted by Rev1.	Deoxycytidine Monophosphate	0-4	DNA polymerase mu	Homo sapiens	47-56
20726503-8	2010	dCMP and dTMP were most frequently inserted by hPol iota, and only dCMP was inserted by Rev1.	Deoxycytidine Monophosphate	67-71	REV1 DNA directed polymerase	Homo sapiens	88-92
20703783-1	2011	A new bis(diphenylphosphate)diimine ligand (BP1) was prepared and evaluated for its ability for selective detection of deoxycytidine 5"-monophosphate (dCMP).	Deoxycytidine Monophosphate	119-149	BP1	Homo sapiens	44-47
20703783-1	2011	A new bis(diphenylphosphate)diimine ligand (BP1) was prepared and evaluated for its ability for selective detection of deoxycytidine 5"-monophosphate (dCMP).	Deoxycytidine Monophosphate	151-155	BP1	Homo sapiens	44-47
20703783-2	2011	BP1 exhibited off-type fluorescence in the presence of dCMP.	Deoxycytidine Monophosphate	55-59	BP1	Homo sapiens	0-3
20703783-3	2011	The fluorescence of BP1 was significantly quenched upon the addition of 2.5 x 10(-4) M dCMP and the detection limit was 1.25 x 10(-5) M in MeCN-H(2)O (1:1, v/v).	Deoxycytidine Monophosphate	87-91	BP1	Homo sapiens	20-23
20703783-4	2011	The binding ratio between BP1 and dCMP was determined to be 1:1 with the binding constant of 3.98 +- 0.60 x 10(-3) M(-1).	Deoxycytidine Monophosphate	34-38	BP1	Homo sapiens	26-29
19765547-3	2010	Human UMP/CMP kinase (UMP/CMPK; cytidylate kinase; EC 2.7.4.14) is thought to be responsible for phosphorylation of UMP, CMP, and dCMP and may also play an important role in the activation of pyrimidine analogs.	Deoxycytidine Monophosphate	130-134	cytidine/uridine monophosphate kinase 1	Homo sapiens	6-20
19765547-3	2010	Human UMP/CMP kinase (UMP/CMPK; cytidylate kinase; EC 2.7.4.14) is thought to be responsible for phosphorylation of UMP, CMP, and dCMP and may also play an important role in the activation of pyrimidine analogs.	Deoxycytidine Monophosphate	130-134	cytidine/uridine monophosphate kinase 1	Homo sapiens	22-30
19765547-3	2010	Human UMP/CMP kinase (UMP/CMPK; cytidylate kinase; EC 2.7.4.14) is thought to be responsible for phosphorylation of UMP, CMP, and dCMP and may also play an important role in the activation of pyrimidine analogs.	Deoxycytidine Monophosphate	130-134	cytidine/uridine monophosphate kinase 1	Homo sapiens	32-49
19765547-3	2010	Human UMP/CMP kinase (UMP/CMPK; cytidylate kinase; EC 2.7.4.14) is thought to be responsible for phosphorylation of UMP, CMP, and dCMP and may also play an important role in the activation of pyrimidine analogs.	Deoxycytidine Monophosphate	130-134	cytidine/uridine monophosphate kinase 1	Homo sapiens	6-9
18984581-3	2009	DNA polymerase iota incorporates dCMP opposite N2-ethyl-Gua and unadducted Gua with similar efficiencies in the presence of Mg2+ and with greater efficiencies in the presence of Mn2+.	Deoxycytidine Monophosphate	33-37	DNA polymerase iota	Homo sapiens	0-19
19220460-9	2009	These results show that RS21-C6 produces dCMP, an upstream precursor for the de novo synthesis of dTTP, by hydrolyzing canonical dCTP.	Deoxycytidine Monophosphate	41-45	dCTP pyrophosphatase 1	Homo sapiens	24-31
19337797-8	2009	In subanalyses according to CHF etiology the LEPR Gln223Arg showed an independent prediction role for NYHA IV in IHD patients (P = 0.0001, OR = 2.50, 95% CI = 1.69-3.82) and both for NYHA IV(P = 0.007, OR = 2.04, 95% CI = 1.20-3.84) and LVEF (P = 0.004, OR = 11.87, 95% CI = 2.08-55.6) in DCMP patients.	Deoxycytidine Monophosphate	289-293	leptin receptor	Homo sapiens	45-49
18084067-3	2007	Here, the structures of dCK complexes with the products dCMP, UDP and Mg2+ ion, and with dAMP, UDP and Mg2+ ion are reported.	Deoxycytidine Monophosphate	56-60	Calcium/calmodulin-dependent protein kinase II	Drosophila melanogaster	24-27
18343960-1	2008	Bacterial cytidylate kinase or cytidine monophosphate kinase (CMP kinase) catalyses the phosphoryl transfer from ATP to CMP and dCMP, resulting in the formation nucleoside diphosphates.	Deoxycytidine Monophosphate	128-132	cytidylate kinase	Mycobacterium tuberculosis H37Rv	10-27
18304575-8	2008	All pols, that is, pol alpha, pol eta, and pol kappaDeltaC, promoted preferential incorporation of 2"-deoxycytidine monophosphate (dCMP), the wrong base, opposite the dI lesion.	Deoxycytidine Monophosphate	131-135	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	19-28
18304575-10	2008	Steady-state kinetic studies with pol alpha, pol eta, and pol kappaDeltaC indicated that dCMP was preferentially incorporated opposite the dI lesion.	Deoxycytidine Monophosphate	89-93	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	34-43
18079151-4	2008	We observed that human DNA polymerase kappa (Pol kappa) inserts dGMP and dCMP within the [T](11) mononucleotide repeat, producing an interrupted 12-bp allele.	Deoxycytidine Monophosphate	73-77	DNA polymerase kappa	Homo sapiens	23-43
18079151-4	2008	We observed that human DNA polymerase kappa (Pol kappa) inserts dGMP and dCMP within the [T](11) mononucleotide repeat, producing an interrupted 12-bp allele.	Deoxycytidine Monophosphate	73-77	DNA polymerase lambda	Homo sapiens	45-54
17999954-6	2008	The enzyme was able to phosphorylate dUMP, dCMP, CMP, and UMP with ATP as phosphate donor, but the kinetic properties were different compared with the cytosolic UMP-CMPK.	Deoxycytidine Monophosphate	43-47	cytidine/uridine monophosphate kinase 2	Homo sapiens	161-169
18522277-6	2008	The kinetic parameters of APE1 exonuclease excision of mismatched dCMP and dTMP from the 3" terminus of single-strand DNA and from photoreactive dCMP analogues applied for photoaffinity modification of proteins and DNA in recombinant systems and cell/nuclear extracts were determined.	Deoxycytidine Monophosphate	66-70	apurinic/apyrimidinic endodeoxyribonuclease 1	Homo sapiens	26-30
18522277-6	2008	The kinetic parameters of APE1 exonuclease excision of mismatched dCMP and dTMP from the 3" terminus of single-strand DNA and from photoreactive dCMP analogues applied for photoaffinity modification of proteins and DNA in recombinant systems and cell/nuclear extracts were determined.	Deoxycytidine Monophosphate	145-149	apurinic/apyrimidinic endodeoxyribonuclease 1	Homo sapiens	26-30
17652324-1	2007	The harmfulness of 8-oxo-7,8-dihydro-2"-deoxyguanosine (8oxodG) damage resides on its dual coding potential, as it can pair with the correct dCMP (dC) or the incorrect dAMP (dA).	Deoxycytidine Monophosphate	141-145	Amphiphysin	Drosophila melanogaster	168-172
17827267-5	2007	AtREV1 also inserted a dCMP opposite an apurinic/apyrimidinic site, which is physiologically generated or induced by various DNA-damaging agents.	Deoxycytidine Monophosphate	23-27	DNA-directed DNA polymerase	Arabidopsis thaliana	0-6
18066785-1	2007	Human UMP-CMP kinase is involved in the phosphorylation of nucleic acid precursors and also in the activation of antiviral analogues including cidofovir, an acyclic phosphonate compound that mimicks dCMP and shows a broad antiviral spectrum.	Deoxycytidine Monophosphate	199-203	cytidine/uridine monophosphate kinase 2	Homo sapiens	6-20
16314579-8	2005	These results support a major role for Rev1-dependent dCMP insertion across from AP sites and a lesser role for dAMP insertion.	Deoxycytidine Monophosphate	54-58	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	39-43
17002316-5	2006	The primer extension reaction catalyzed by pol kappa deltaC, a truncated form of pol kappa, extended more efficiently past the adduct than that of pol eta by incorporating dCMP, a correct base, opposite the adduct.	Deoxycytidine Monophosphate	172-176	DNA polymerase lambda	Homo sapiens	43-52
17002316-5	2006	The primer extension reaction catalyzed by pol kappa deltaC, a truncated form of pol kappa, extended more efficiently past the adduct than that of pol eta by incorporating dCMP, a correct base, opposite the adduct.	Deoxycytidine Monophosphate	172-176	DNA polymerase lambda	Homo sapiens	81-90
16417454-10	2005	The photoreactive dCMP moiety was introduced into the 3"-end of DNA primer via the activity of Pol beta.	Deoxycytidine Monophosphate	18-22	DNA polymerase beta	Homo sapiens	95-103
16681391-10	2006	In addition, pol eta and pol kappa bypassed the lesion by incorporating dAMP and dCMP, respectively, opposite the lesion and extended past the lesion.	Deoxycytidine Monophosphate	81-85	DNA polymerase lambda	Homo sapiens	25-34
16546083-3	2006	Rev1 acts as a deoxycytidyl transferase, inserting dCMP opposite lesions.	Deoxycytidine Monophosphate	51-55	deoxycytidyl transferase	Saccharomyces cerevisiae S288C	0-4
16489926-5	2006	We have studied 3 -5 exonuclease activity of APE1 towards dCMP and dTMP residues and modified dCMP analogs with photoreactive groups at the 3 end of the nicked DNA.	Deoxycytidine Monophosphate	58-62	apurinic/apyrimidinic endodeoxyribonuclease 1	Homo sapiens	45-49
15550676-1	2005	Human UMP/CMP kinase (cytidylate kinase; EC 2.7.4.14) is responsible for phosphorylation of CMP, UMP, and deoxycytidine monophosphate (dCMP) and also plays an important role in the activation of pyrimidine analogs, some of which are clinically useful anticancer or antiviral drugs.	Deoxycytidine Monophosphate	106-133	cytidine/uridine monophosphate kinase 1	Homo sapiens	6-20
15938713-4	2005	In the direct mutagenesis experiments, Polkappa was found to be more mutagenic than Poleta studied previously: it inserted dAMP more efficiently than dCMP opposite 8-OH-G. Polkappa was also able to cause indirect mispair ("action-at-a-distance" mutagenesis), this effect being more distinct on mouse templates.	Deoxycytidine Monophosphate	150-154	DNA polymerase lambda	Homo sapiens	172-180
15966748-3	2005	Primer extension reactions catalyzed by pol alpha or beta were strongly retarded at the 8-NO(2)-dG lesion; a fraction of primers was extended past the lesion by incorporating preferentially dCMP, the correct base, opposite the lesion, accompanied by lesser amounts of dAMP and dGMP incorporation.	Deoxycytidine Monophosphate	190-194	DNA polymerase alpha 1, catalytic subunit	Homo sapiens	40-49
15550676-1	2005	Human UMP/CMP kinase (cytidylate kinase; EC 2.7.4.14) is responsible for phosphorylation of CMP, UMP, and deoxycytidine monophosphate (dCMP) and also plays an important role in the activation of pyrimidine analogs, some of which are clinically useful anticancer or antiviral drugs.	Deoxycytidine Monophosphate	106-133	cmp	Drosophila melanogaster	10-13
15550676-1	2005	Human UMP/CMP kinase (cytidylate kinase; EC 2.7.4.14) is responsible for phosphorylation of CMP, UMP, and deoxycytidine monophosphate (dCMP) and also plays an important role in the activation of pyrimidine analogs, some of which are clinically useful anticancer or antiviral drugs.	Deoxycytidine Monophosphate	135-139	cytidine/uridine monophosphate kinase 1	Homo sapiens	6-20
15550676-1	2005	Human UMP/CMP kinase (cytidylate kinase; EC 2.7.4.14) is responsible for phosphorylation of CMP, UMP, and deoxycytidine monophosphate (dCMP) and also plays an important role in the activation of pyrimidine analogs, some of which are clinically useful anticancer or antiviral drugs.	Deoxycytidine Monophosphate	135-139	cmp	Drosophila melanogaster	10-13
15550676-2	2005	Previous kinetic data using recombinant or highly purified human UMP/CMP kinase showed that dCMP, as well as pyrimidine analog monophosphates, were much poorer substrates than CMP or UMP for this enzyme.	Deoxycytidine Monophosphate	92-96	cytidine/uridine monophosphate kinase 1	Homo sapiens	65-79
15550676-2	2005	Previous kinetic data using recombinant or highly purified human UMP/CMP kinase showed that dCMP, as well as pyrimidine analog monophosphates, were much poorer substrates than CMP or UMP for this enzyme.	Deoxycytidine Monophosphate	92-96	cmp	Drosophila melanogaster	69-72
15550676-4	2005	Here, we reevaluated the optimal reaction conditions for human recombinant human UMP/CMP kinase to phosphorylate dCMP and CMP (referred as dCMPK and CMPK activities).	Deoxycytidine Monophosphate	113-117	cytidine/uridine monophosphate kinase 1	Homo sapiens	81-95
15550676-4	2005	Here, we reevaluated the optimal reaction conditions for human recombinant human UMP/CMP kinase to phosphorylate dCMP and CMP (referred as dCMPK and CMPK activities).	Deoxycytidine Monophosphate	113-117	cmp	Drosophila melanogaster	85-88
15550676-4	2005	Here, we reevaluated the optimal reaction conditions for human recombinant human UMP/CMP kinase to phosphorylate dCMP and CMP (referred as dCMPK and CMPK activities).	Deoxycytidine Monophosphate	113-117	cytidine/uridine monophosphate kinase 1	Homo sapiens	140-144
15550676-9	2005	The data suggest that the active sites of human UMP/CMP kinase for dCMP and for CMP cannot be identical.	Deoxycytidine Monophosphate	67-71	cytidine/uridine monophosphate kinase 1	Homo sapiens	48-62
15550676-9	2005	The data suggest that the active sites of human UMP/CMP kinase for dCMP and for CMP cannot be identical.	Deoxycytidine Monophosphate	67-71	cmp	Drosophila melanogaster	52-55
15550676-10	2005	Furthermore, enzyme inhibition studies demonstrated that CMP could inhibit dCMP phosphorylation in a noncompetitive manner, with Ki values much higher than its own Km values.	Deoxycytidine Monophosphate	75-79	cmp	Drosophila melanogaster	57-60
14592433-4	2003	The kinase, encoded by the dak1 gene, was approximately 60% similar to the human UMP-CMP kinase and predominantly phosphorylated CMP, dCMP, and UMP.	Deoxycytidine Monophosphate	134-138	cytidine/uridine monophosphate kinase 1	Homo sapiens	81-95
15554708-7	2004	Both pol eta and pol kappa incorporated dCMP, the correct base, opposite dG-N(2)-AAF.	Deoxycytidine Monophosphate	40-44	DNA polymerase lambda	Homo sapiens	17-26
15533436-7	2004	When pol beta was used, direct incorporation of correct dCMP was primarily observed, accompanied by small amounts of misincorporation of dTMP, dAMP and dGMP.	Deoxycytidine Monophosphate	56-60	DNA polymerase beta	Homo sapiens	5-13
15504034-5	2004	The molecular topology of dCD is related to that of cytidine deaminase (CDA) but with modifications for formation of the binding site for the phosphate group of dCMP.	Deoxycytidine Monophosphate	161-165	cytidine deaminase	Homo sapiens	72-75
15388802-9	2004	Our current model suggests that the Rad6-Rad18 complex targets Poleta at DNA gaps that result from the MMR-mediated excision of adenine mispaired with 8-oxoG, allowing error-free dCMP incorporation opposite to this lesion.	Deoxycytidine Monophosphate	179-183	E2 ubiquitin-conjugating protein RAD6	Saccharomyces cerevisiae S288C	36-40
15388802-9	2004	Our current model suggests that the Rad6-Rad18 complex targets Poleta at DNA gaps that result from the MMR-mediated excision of adenine mispaired with 8-oxoG, allowing error-free dCMP incorporation opposite to this lesion.	Deoxycytidine Monophosphate	179-183	E3 ubiquitin-protein ligase RAD18	Saccharomyces cerevisiae S288C	41-46
15366941-6	2004	Steady-state kinetic studies showed that both pol kappa and pol eta inserted dCMP and dAMP opposite the 4-OHEN-dC and extended past the lesion.	Deoxycytidine Monophosphate	77-81	DNA polymerase lambda	Homo sapiens	46-55
12584190-6	2003	The in vitro results also suggested the involvement of pol iota and/or REV1 in inserting correct dCMP opposite alpha-OH-PdG during error-free synthesis.	Deoxycytidine Monophosphate	97-101	REV1 DNA directed polymerase	Homo sapiens	71-75
12488542-1	2003	Deoxycytidylate deaminase, catalyzing the conversion of dCMP to dUMP, is an important enzyme in the de novo synthesis of thymidine nucleotides.	Deoxycytidine Monophosphate	56-60	dCMP deaminase	Homo sapiens	0-25
12771412-2	2003	Here, we have demonstrated that HCMV increases expression of the cellular deoxycytidylate deaminase (dCMP deaminase), which provides the substrate for TS by converting dCMP to dUMP.	Deoxycytidine Monophosphate	101-105	dCMP deaminase	Homo sapiens	74-99